BioCardia, Inc. (BCDA)

NASDAQ: BCDA · Delayed Price · USD
1.57
-0.02 (-1.26%)
At close: Jan 26, 2022 4:00 PM
1.55
-0.02 (-1.27%)
After-hours:Jan 26, 2022 6:38 PM EST

Total Valuation

BioCardia has a market cap or net worth of $26.49 million. The enterprise value is $10.76 million.

Market Cap26.49M
Enterprise Value10.76M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

BioCardia has 16.87 million shares outstanding. The number of shares has increased by 35.25% in one year.

Shares Outstanding16.87M
Shares Change (YoY)+35.25%
Shares Change (QoQ)+0.11%
Owned by Insiders (%)30.96%
Owned by Institutions (%)22.75%
Float11.17M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio26.97
PB Ratio1.97
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Sales10.96
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 4.34, with a Debt / Equity ratio of 0.01.

Current Ratio4.34
Quick Ratio4.25
Debt / Equity0.01
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -72.70%, which is considered low.

Return on Equity (ROE)-72.70%
Return on Assets (ROA)-57.70%
Return on Capital (ROIC)n/a
Revenue Per Employee$40,917
Profits Per Employee-$506,292
Employee Count24
Asset Turnover0.05
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

The stock price has decreased by -59.42% in the last 52 weeks. The beta is 1.43, so BioCardia's price volatility has been higher than the market average.

Beta (1Y)1.43
52-Week Price Change-59.42%
50-Day Moving Average1.88
200-Day Moving Average2.69
Average Volume (30 Days)151,669

Short Selling Information

Short Interest257,269
Short % of Shares Out1.52%
Short % of Float2.30%
Short Ratio (days to cover)0.83

Income Statement

In the last 12 months, BioCardia had revenue of $982,000 and -12.15 million in losses. Earnings per share was -$0.76.

Revenue982,000
Gross Profit982,000
Operating Income-12.67M
Net Income-12.15M
EBITDA-11.54M
EBIT-12.15M
Earnings Per Share (EPS)-$0.76
Full Income Statement

Balance Sheet

The company has $15.89 million in cash and $161,000 in debt, giving a net cash position of $15.73 million or $0.93 per share.

Cash & Cash Equivalents15.89M
Total Debt161,000
Net Cash15.73M
Net Cash Per Share$0.93
Book Value13.41M
Book Value Per Share0.79
Working Capital13.09M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.81 million and capital expenditures -$75,000, giving a free cash flow of -$10.88 million.

Operating Cash Flow-10.81M
Capital Expenditures-75,000
Free Cash Flow-10.88M
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -1,289.92% and -1,237.37%.

Gross Margin100.00%
Operating Margin-1,289.92%
Pretax Marginn/a
Profit Margin-1,237.37%
EBITDA Margin-1,175.25%
EBIT Margin-1,237.27%
FCF Margin-1,108.25%

Dividends & Yields

BioCardia does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-45.87%
FCF Yield-41.09%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

The last stock split was on June 6, 2019. It was a reverse split with a ratio of 1:9.

Last Split DateJun 6, 2019
Split TypeReverse
Split Ratio1:9